Clinical trials

  • RIVAROXABAN for Hip osteoarthritis
  • IPH5201 for Non-small cell lung cancer (stage II–III)
  • ROSUVASTATIN CALCIUM for Statin intolerance | High cardiovascular risk (previous cardiovascular disease or familial hypercholesterolemia)
  • CLADRIBINE for Generalized Myasthenia Gravis
  • DAROLUTAMIDE for Castration-resistant prostate cancer|Oligometastatic prostate cancer
  • recombinant chimeric bacteriophage endolysin HY-133 for Nasal colonization with methicillin-susceptible Staphylococcus aureus (MSSA)
  • RELATLIMAB for Muscle-invasive bladder cancer (urothelial carcinoma), stage II–IIIa
  • Methotrexate for Rheumatoid arthritis
  • Clinical trial in Vitiligo
  • SELPERCATINIB for RET fusion-positive solid tumor | Medullary thyroid cancer | Non-small cell lung cancer
  • FINERENONE for Chronic kidney disease
  • PIRTOBRUTINIB for Chronic lymphocytic leukemia | Small lymphocytic lymphoma